BlueTree Allied Angels is a members-only group of accredited investors focused on funding promising start-up companies. It is self-described as Western Pennsylvania's leading angel network.

BlueTree Allied Angels

Harvard Business School Alumni Angels of Greater New York is an angel investment group comprised of alumni from Harvard Business School and other Harvard University graduates who invest in early-stage companies.

Harvard Business School Alumni Angels of Greater New York

Sierra Angels is an angel investment group that focuses on funding seed-stage technology companies with capital-efficient models and a B2B emphasis. Self-described as fostering innovation and supporting economic growth, Sierra Angels engages in mentoring and strategic introductions.

Sierra Angels

T5 Partners is a private investment firm focused on angel investment, venture capital, and M&A for organizations looking to launch, exit, or grow.

T5 Partners

We invest time and capital in strong early-stage companies to help them succeed.

Wombat Security Technologies

DiaKine Therapeutics

TalkShoe

Voci Technologies

NewCare Solutions

C360 Technologies

ALung Technologies

Cognition Therapeutics

See what Lindsay Watson PT, MPT, Co-founder and CEO of Augment Therapy, says about the #northeastohioregion! Learn more about her thoughts on the assets and strengths of Northeast Ohio as an entrepreneur in the region by clicking here➡️https://bit.ly/3EM4FQg

#NEOhio #TeamNEO #EconDev #economicvibrancy #vibranteconomy #VEI

CytoAgents is at the forefront of biotech innovation, developing an effective solution for Cytokine Release Syndrome (CRS), otherwise known as Cytokine Storm.

Our CEO, Teresa Whalen, RPh, is leading the charge to bring our life-changing drug to market. She is an experienced biotech leader who has a successful track record as a healthcare executive and investor. She has also been called on to report on innovation and emerging technology for state policymakers.

Learn more about Teresa and the CytoAgents leadership team here: https://lnkd.in/g7P29x3i

#biotechnology #biotech #healthcareleaders #cycokinereleasesyndrome

Chimeric antigen receptor (CAR) T-cell therapy is changing the landscape for treatment options for patients with certain types of cancer. Researchers continue to look for ways to expand this therapy to impact a greater number of patients.

One major risk to this form of treatment is a life-threatening side effect known as Cytokine Release Syndrome (CRS), which is an overreaction of the immune system. Learn how CytoAgents' solution will address this side effect and make CAR T-cell therapy safer for patients: https://cytoagents.com/

#cytokinereleasesyndrome #crs #cytokines #cartcelltherapy Teresa Whalen, RPh

Looking forward to seeing where this partnership takes both companies.  A great solution for a population that needs ways to more efficiently do their job.

Metric
Company Name	BlueTree Allied Angels	Harvard Business School Alumni Angels of Greater New York	Sierra Angels	T5 Partners
Symbol
MSH ID	COM:BLUETREEALLIEDANGELS	COM:HBSANGELSNY	COM:SIERRAANGELS	COM:T5-PARTNERS
Market	PRIVATE	PRIVATE	PRIVATE	PRIVATE
Sector	Financial Services & Finance	Financial Services & Finance	Financial Services & Finance	Financial Services & Finance
Industry	Angel Investing	Venture Capital	Venture Capital	Investment Management
Country	US	US	US	US
Stage
Employee Count	14
Website	bluetreealliedangels.com	hbsangelsny.com	sierraangels.com	t5-partners.com
LinkedIn	bluetree-allied-angels
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic			41
Web Traffic Growth			0.06
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

BLUE

COM:BLUETREEALLIEDANGELS

BlueTree Allied Angels

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue